Population Pharmacokinetic Modelling to Support the Evaluation of Preclinical Pharmacokinetic Experiments with Lorlatinib
Open Access
- 23 September 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Pharmaceutical Sciences
- Vol. 111 (2), 495-504
- https://doi.org/10.1016/j.xphs.2021.09.029
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Modeling and Simulation Workbench for NONMEM: Tutorial on Pirana, PsN, and XposeCPT: Pharmacometrics & Systems Pharmacology, 2013
- Pharmacokinetics and ToxicokineticsPublished by Elsevier BV ,2013
- The role of ABC transporters in drug absorption, distribution, metabolism, excretion and toxicity (ADME–Tox)Drug Discovery Today, 2008
- Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolismJCI Insight, 2007
- Multidrug resistance proteins: role of P-glycoprotein, MRP1, MRP2, and BCRP (ABCG2) in tissue defenseToxicology and Applied Pharmacology, 2005
- Enterohepatic CirculationClinical Pharmacokinetics, 2002
- A General Model for the Origin of Allometric Scaling Laws in BiologyScience, 1997
- Noncompartmental Versus Compartmental Modelling in Clinical PharmacokineticsClinical Pharmacokinetics, 1991
- Population PharmacokineticsThe Journal of Clinical Pharmacology, 1988
- The Population Approach to Pharmacokinetic Data Analysis: Rationale and Standard Data Analysis MethodsDrug Metabolism Reviews, 1984